Finance

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Iambic Therapeutics, AI-Driven Drug Discovery and Development, Files for Nasdaq Global Select Market IPO

Equal-weight failed. Now tech stocks look shaky again. So what should you do about S&P 500 risk?

Frazier Life Sciences SPAC raises $75M in Nasdaq IPO